Co-Authors
This is a "connection" page, showing publications co-authored by Seyed Hashemian and Payam Tabarsi.
Connection Strength
2.671
-
Oxygenation Efforts for Iranian COVID-19 ARDS Patients: First 5-Day Crisis Experience Scenario. Tanaffos. 2020 Jul; 19(3):173-175.
Score: 0.890
-
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS). Pulmonology. 2021 Nov-Dec; 27(6):486-492.
Score: 0.229
-
Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299.
Score: 0.229
-
Iran's Approach to COVID-19: Evolving Treatment Protocols and Ongoing Clinical Trials. Front Public Health. 2020; 8:551889.
Score: 0.225
-
Noninvasive Versus Invasive Ventilation in COVID-19: One Size Does Not Fit All! Anesth Analg. 2020 08; 131(2):e114-e115.
Score: 0.224
-
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688.
Score: 0.221
-
A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol. Iran J Pharm Res. 2020; 19(1):31-36.
Score: 0.215
-
Increased Serum Levels of Soluble TNF-a Receptor Is Associated With ICU Mortality in COVID-19 Patients. Front Immunol. 2021; 12:592727.
Score: 0.059
-
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947.
Score: 0.058
-
NRITLD Protocol for the Management of Patients with COVID-19 Admitted to Hospitals. Tanaffos. 2020 Nov; 19(2):91-99.
Score: 0.057
-
Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128.
Score: 0.057
-
Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients. Int Forum Allergy Rhinol. 2020 10; 10(10):1127-1135.
Score: 0.056
-
Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020 08; 10(8):944-950.
Score: 0.055
-
Investigating PIK3R3 and ATp2A1 Genes Expressions in Ventilator-Associated Pneumonia Patients Admitted to the Intensive Care Unit of Masih Daneshvari Hospital in 2016. Rep Biochem Mol Biol. 2018 Apr; 6(2):118-124.
Score: 0.048
-
Study Protocol on Antimicrobial Stewardship in a Tertiary Respiratory Referral Hospital. Tanaffos. 2018 Mar; 17(3):183-187.
Score: 0.047